Largest health care companies by total liabilities
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
UnitedHealth Group leads the 170 health care companies ranked by total liabilities, at PLN 835.4B, ahead of CVS Health (PLN 715.9B) and AbbVie (PLN 551.3B). Figures as of 19 Nov 2026, 07:17 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 170
- First
- UnitedHealth GroupPLN 835.4B
- Median
- PLN 12.3B
- Combined market value
- PLN 36.55T
- Countries
- 14
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | Total liabilities ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 101 | IDEXX LaboratoriesIDXX · Health Care | PLN 7B | PLN 221.1B | PLN 2,806.90 | 1.19% up | 1% down | ||
| 102 | InsuletPODD · Health Care | PLN 6.7B | PLN 39B | PLN 562.53 | 3.69% down | 58% down | ||
| 103 | Ascendis PharmaASND · Health Care | PLN 6.5B | PLN 71.3B | PLN 1,086.36 | 0.32% down | 28% up | ||
| 104 | Hims & Hers HealthHIMS · Health Care | PLN 6.5B | PLN 16.1B | PLN 68.52 | 2.85% down | 51% down | ||
| 105 | HaemoneticsHAE · Health Care | PLN 6.4B | PLN 22.5B | PLN 493.73 | 1.60% up | 61% up | ||
| 106 | InsmedINSM · Health Care | PLN 6.1B | PLN 105.6B | PLN 481.43 | 1.69% down | 40% down | ||
| 107 | Medpace HoldingsMEDP · Health Care | PLN 6.1B | PLN 72.7B | PLN 2,599.54 | 0.95% down | 10% up | ||
| 108 | BioMarin PharmaceuticalBMRN · Health Care | PLN 6.1B | PLN 47.8B | PLN 246.87 | 4.99% up | 11% up | ||
| 109 | LivaNovaLIVN · Health Care | PLN 5.7B | PLN 20.9B | PLN 379.92 | 2.85% up | 71% up | ||
| 110 | Neurocrine BiosciencesNBIX · Health Care | PLN 5.5B | PLN 66.2B | PLN 654.48 | 1.84% down | 20% up | ||
| 111 | argenxARGX · Health Care | PLN 5.5B | PLN 237.9B | PLN 3,782.54 | 0.66% down | 4% up | ||
| 112 | HealthEquityHQY · Health Care | PLN 5.1B | PLN 32.3B | PLN 391.05 | 4.45% down | 2% down | ||
| 113 | MSA SafetyMSA · Health Care | PLN 4.8B | PLN 27.5B | PLN 713.11 | 2.67% up | 11% up | ||
| 114 | Lantheus HoldingsLNTH · Health Care | PLN 4.6B | PLN 26.8B | PLN 409.90 | 0.20% up | 93% up | ||
| 115 | Merit Medical SystemsMMSI · Health Care | PLN 4.4B | PLN 20.7B | PLN 345.32 | 1.70% up | 1% up | ||
| 116 | West Pharmaceutical ServicesWST · Health Care | PLN 4.4B | PLN 113.1B | PLN 1,623.61 | 2.44% down | 61% up | ||
| 117 | MiniMed GroupMMED · Health Care | PLN 4.1B | PLN 19.2B | PLN 68.28 | 4.44% down | 4% down | ||
| 118 | ImmunityBioIBRX · Health Care | PLN 4B | PLN 28.6B | PLN 26.92 | 7.03% up | 193% up | ||
| 119 | Arrowhead PharmaceuticalsARWR · Health Care | PLN 3.5B | PLN 24.5B | PLN 173.24 | 0.28% up | 10% up | ||
| 120 | RepligenRGEN · Health Care | PLN 3.4B | PLN 44.4B | PLN 693.90 | 6.47% up | 5% up | ||
| 121 | United TherapeuticsUTHR · Health Care | PLN 3.1B | PLN 98.8B | PLN 2,320.12 | 1.16% down | 23% up | ||
| 122 | Legend BiotechLEGN · Health Care | PLN 2.9B | PLN 12.7B | PLN 65.30 | 0.87% up | 42% down | ||
| 123 | Globus MedicalGMED · Health Care | PLN 2.9B | PLN 37.5B | PLN 283.43 | 0.77% up | 16% down | ||
| 124 | Revolution MedicinesRVMD · Health Care | PLN 2.9B | PLN 138.9B | PLN 642.26 | 1.76% down | 131% up | ||
| 125 | NateraNTRA · Health Care | PLN 2.8B | PLN 168.7B | PLN 1,163.40 | 0.71% up | 32% up | ||
| 126 | ExelixisEXEL · Health Care | PLN 2.7B | PLN 67B | PLN 274.43 | 0.31% down | 63% up | ||
| 127 | LifeStance Health GroupLFST · Health Care | PLN 2.7B | PLN 21B | PLN 55.34 | 2.82% down | 129% up | ||
| 128 | AlkermesALKS · Health Care | PLN 2.7B | PLN 31.6B | PLN 188.27 | 3.08% up | 58% up | ||
| 129 | Madrigal PharmaceuticalsMDGL · Health Care | PLN 2.6B | PLN 37.2B | PLN 1,599.74 | 5.67% down | 24% down | ||
| 130 | Axsome TherapeuticsAXSM · Health Care | PLN 2.4B | PLN 28.3B | PLN 538.50 | 1.43% down | 7% down | ||
| 131 | ChemedCHE · Health Care | PLN 2.2B | PLN 28.5B | PLN 2,197.07 | 0.01% down | 27% up | ||
| 132 | Caris Life SciencesCAI · Health Care | PLN 2.2B | PLN 22.5B | PLN 78.36 | 2.21% down | 17% down | ||
| 133 | Ligand PharmaceuticalsLGND · Health Care | PLN 2.2B | PLN 24B | PLN 1,200.41 | 1.67% up | 43% up | ||
| 134 | Mirum PharmaceuticalsMIRM · Health Care | PLN 2.1B | PLN 24.3B | PLN 371.68 | 0.59% up | 31% up | ||
| 135 | Travere TherapeuticsTVTX · Health Care | PLN 2B | PLN 19.4B | PLN 201.90 | 1.68% down | 44% up | ||
| 136 | Bio-TechneTECH · Health Care | PLN 1.9B | PLN 45.9B | PLN 292.36 | 0.17% up | 26% up | ||
| 137 | Roivant SciencesROIV · Health Care | PLN 1.7B | PLN 112.8B | PLN 155.64 | 0.05% up | 90% up | ||
| 138 | TG TherapeuticsTGTX · Health Care | PLN 1.7B | PLN 40.2B | PLN 265.71 | 5.44% up | 107% up | ||
| 139 | PenumbraPEN · Health Care | PLN 1.6B | PLN 50.8B | PLN 1,288.38 | 0.47% up | 13% up | ||
| 140 | GRAILGRAL · Health Care | PLN 1.4B | PLN 18.4B | PLN 410.30 | 3.57% down | 20% up | ||
| 141 | CRISPR TherapeuticsCRSP · Health Care | PLN 1.4B | PLN 15.7B | PLN 161.51 | 0.10% up | 21% down | ||
| 142 | VaxcytePCVX · Health Care | PLN 1.3B | PLN 37.2B | PLN 235.17 | 1.48% down | 22% up | ||
| 143 | Cogent BiosciencesCOGT · Health Care | PLN 1.2B | PLN 19.4B | PLN 111.76 | 0.14% down | 20% down | ||
| 144 | Adaptive BiotechnologiesADPT · Health Care | PLN 1.2B | PLN 18.5B | PLN 114.37 | 0.11% down | 88% up | ||
| 145 | 10x GenomicsTXG · Health Care | PLN 984.7M | PLN 30.2B | PLN 229.34 | 1.37% up | 260% up | ||
| 146 | GlaukosGKOS · Health Care | PLN 953.8M | PLN 55.4B | PLN 936.66 | 4.18% down | 152% up | ||
| 147 | Rhythm PharmaceuticalsRYTM · Health Care | PLN 844.6M | PLN 33.2B | PLN 478.38 | 2.08% up | 13% up | ||
| 148 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | PLN 787.8M | PLN 30B | PLN 381.97 | 0.06% down | 126% up | ||
| 149 | Kodiak SciencesKOD · Health Care | PLN 780.2M | PLN 25.7B | PLN 393.06 | 1.04% up | 396% up | ||
| 150 | Corcept TherapeuticsCORT · Health Care | PLN 758.9M | PLN 29.8B | PLN 272.42 | 3.25% down | 8% down | ||
| 151 | Twist BioscienceTWST · Health Care | PLN 678.8M | PLN 31.9B | PLN 467.57 | 3.88% up | 340% up | ||
| 152 | Kymera TherapeuticsKYMR · Health Care | PLN 655.6M | PLN 41.6B | PLN 486.78 | 0.32% down | 87% up | ||
| 153 | Scholar Rock HoldingSRRK · Health Care | PLN 638.1M | PLN 23.5B | PLN 192.89 | 6.48% up | 14% up | ||
| 154 | BillionToOneBLLN · Health Care | PLN 613M | PLN 17.6B | PLN 367.87 | 6.11% down | 0% up | ||
| 155 | ABIVAXABVX · Health Care | PLN 575.8M | PLN 29.5B | PLN 336.88 | 2.11% up | 27% down | ||
| 156 | Krystal BiotechKRYS · Health Care | PLN 459.1M | PLN 37.6B | PLN 1,267.24 | 5.62% up | 46% up | ||
| 157 | Definium TherapeuticsDFTX · Health Care | PLN 433.1M | PLN 16B | PLN 117.02 | 0.88% down | 169% up | ||
| 158 | ImmunovantIMVT · Health Care | PLN 419.6M | PLN 27.6B | PLN 133.30 | 0.12% down | 43% up | ||
| 159 | Summit TherapeuticsSMMT · Health Care | PLN 371M | PLN 33.7B | PLN 42.20 | 1.59% down | 36% down | ||
| 160 | ErascaERAS · Health Care | PLN 285.3M | PLN 19.4B | PLN 55.30 | 0.94% down | 403% up | ||
| 161 | Spyre TherapeuticsSYRE · Health Care | PLN 251.3M | PLN 38.7B | PLN 407.73 | 8.15% up | 286% up | ||
| 162 | Praxis Precision MedicinesPRAX · Health Care | PLN 240.2M | PLN 34.3B | PLN 1,226.45 | 0.04% up | 61% up | ||
| 163 | HeartflowHTFL · Health Care | PLN 236.3M | PLN 16.2B | PLN 184.42 | 2.51% down | 73% up | ||
| 164 | Protagonist TherapeuticsPTGX · Health Care | PLN 214.9M | PLN 33.4B | PLN 511.01 | 2.00% up | 46% up | ||
| 165 | CG OncologyCGON · Health Care | PLN 156.7M | PLN 28.7B | PLN 321.49 | 1.34% up | 85% up | ||
| 166 | Dianthus TherapeuticsDNTH · Health Care | PLN 150.8M | PLN 19B | PLN 337.49 | 3.45% down | 113% up | ||
| 167 | Edgewise TherapeuticsEWTX · Health Care | PLN 121.9M | PLN 18.2B | PLN 166.25 | 1.59% down | 88% up | ||
| 168 | Oruka TherapeuticsORKA · Health Care | PLN 67.1M | PLN 26.1B | PLN 384.74 | 0.60% down | 241% up | ||
| 169 | Belite BioBLTE · Health Care | PLN 40.5M | PLN 25.5B | PLN 627.83 | 0.94% down | 31% up | ||
| 170 | VeradermicsMANE · Health Care | PLN 36.8M | PLN 21.2B | PLN 501.77 | 0.62% down | 233% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total liabilities is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Where a company reports no total-liabilities line, it is worked out as assets less equity. Sums are converted from US dollars at today's exchange rate (1 USD = 4.0186 PLN).
Questions and answers
Which health care companies rank first by total liabilities?
UnitedHealth Group (PLN 835.4B), CVS Health (PLN 715.9B) and AbbVie (PLN 551.3B) are the top three of the 170 health care companies ranked by total liabilities as of 19 Nov 2026, 07:17 UTC.
How many health care companies are in this ranking?
170 are ranked by total liabilities.
What are these health care companies worth together?
The 170 health care companies ranked by total liabilities have a combined market value of PLN 36.55T as of 19 Nov 2026, 07:17 UTC.
What does ranking by total liabilities measure?
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest health care companies by total liabilities”, data as of 19 November 2026. https://funkfolio.com/companies/sector/health-care?by=total-liabilities
Underlying data: Yahoo Finance; SEC EDGAR.